1. Home
  2. THRD vs CDZI Comparison

THRD vs CDZI Comparison

Compare THRD & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • CDZI
  • Stock Information
  • Founded
  • THRD 2019
  • CDZI 1983
  • Country
  • THRD United States
  • CDZI United States
  • Employees
  • THRD N/A
  • CDZI N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • CDZI Water Supply
  • Sector
  • THRD Health Care
  • CDZI Utilities
  • Exchange
  • THRD Nasdaq
  • CDZI Nasdaq
  • Market Cap
  • THRD 238.7M
  • CDZI 266.1M
  • IPO Year
  • THRD 2022
  • CDZI N/A
  • Fundamental
  • Price
  • THRD $5.46
  • CDZI $2.99
  • Analyst Decision
  • THRD Hold
  • CDZI
  • Analyst Count
  • THRD 3
  • CDZI 0
  • Target Price
  • THRD $5.00
  • CDZI N/A
  • AVG Volume (30 Days)
  • THRD 220.4K
  • CDZI 549.8K
  • Earning Date
  • THRD 08-07-2025
  • CDZI 08-12-2025
  • Dividend Yield
  • THRD N/A
  • CDZI N/A
  • EPS Growth
  • THRD N/A
  • CDZI N/A
  • EPS
  • THRD N/A
  • CDZI N/A
  • Revenue
  • THRD N/A
  • CDZI $11,441,000.00
  • Revenue This Year
  • THRD N/A
  • CDZI $68.68
  • Revenue Next Year
  • THRD N/A
  • CDZI $16.42
  • P/E Ratio
  • THRD N/A
  • CDZI N/A
  • Revenue Growth
  • THRD N/A
  • CDZI 283.67
  • 52 Week Low
  • THRD $3.18
  • CDZI $2.13
  • 52 Week High
  • THRD $16.02
  • CDZI $5.68
  • Technical
  • Relative Strength Index (RSI)
  • THRD 66.73
  • CDZI 48.57
  • Support Level
  • THRD $5.42
  • CDZI $2.93
  • Resistance Level
  • THRD $5.45
  • CDZI $3.09
  • Average True Range (ATR)
  • THRD 0.04
  • CDZI 0.14
  • MACD
  • THRD -0.01
  • CDZI -0.01
  • Stochastic Oscillator
  • THRD 50.00
  • CDZI 18.57

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

Share on Social Networks: